← All stocks

Niagen Bioscience, Inc.

NAGE Net buying

CIK 0001386570 #3766 in the set updated 22 Sep 2026

Bought (12 mo)

$45.62K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$45.62K

+$45.62K against sales at will

By person

4 insiders · 3 transactions

11.2×

Robert Fried holds 11.2 times base salary in stock. $7.26M of shares against $645.96K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert Fried last reported holding, valued at $6.85, the price Common Stock was last bought or sold at on the open market here, on 14 Nov 2025.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Pamir Ozan

Chief Financial Officer

$45.62K (2)

—

+$45.62K

13,848

0.0175%

$94.86K

—

Fried Robert N

Chief Executive Officer

—

1,060,087

1.34%

$7.26M

+9.0%

Jaksch Frank L Jr

Director

—

244,179

0.3086%

$1.67M

+5.6%

Lopez Carlos Luis

SVP, General Counsel

—

4,565

0.0058%

$31.27K

+130.8%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 15

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 27,675

History held since 2 Sep 2016